Infection and drug resistance · 2026
Hospital-Based Surveillance of Klebsiella pneumoniae and Other Klebsiella species in Southern Saudi Arabia (2012-2024): Escalating Carbapenem and DTR Resistance with Species-Specific Phenotypes and Genotypes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shabi Yahya, Algarni Abdullah M, Binkhamis Khalifa, Al Bshabshe Ali, Alazraqi Tarik, Abdullah Mohammed Safia, Habbash Sara, Alqahtani Abdulah J, Basheer Nada A, Alhazmi Abdulaziz H, Patriquin Glenn, Bawazeer Abdulah O S, Tahtouh Esmahan Ibrahim
Аннотация
BACKGROUND: Klebsiella species, particularly Klebsiella pneumoniae, are major healthcare-associated infections showing increasing resistance to carbapenems and other antibiotics. In Saudi Arabia, rising antimicrobial resistance (AMR) and the emergence of difficult-to-treat resistance (DTR) phenotypes pose significant clinical challenges.
METHODS: A 12-year retrospective surveillance study (2012-2024) of 9790 non-duplicate Klebsiella isolates from Aseer Central Hospital in southern Saudi Arabia. Species-level identification, antimicrobial susceptibility testing for each isolate was done. Molecular characterization of carbapenemase genes for selected isolates were performed. Temporal resistance trends were assessed using logistic regression.
RESULTS: K. pneumoniae accounted for 93.0% of isolates, with non-pneumoniae species showing distinct resistance profiles. Carbapenem resistance surged from 12.4% in 2012 to 69.3% in 2021, while DTR prevalence rose to 50.7%. ICU and inpatient settings exhibited the highest resistance rates. Molecular testing revealed widespread bla_OXA-48-like (35.7%), bla_NDM (17.9%), and emerging bla_KPC (14.3%) genes, with 25% of isolates co-harboring multiple carbapenemases. Progression from colonization to bloodstream infection occurred in 1.7% of K. pneumoniae cases, primarily from respiratory and urinary sources.
CONCLUSION: This study highlights escalating carbapenem and DTR resistance among Klebsiella species in southern Saudi Arabia, driven by species-specific mechanisms and widespread carbapenemase gene dissemination. Findings underscore the need for species-level diagnostics, expanded molecular surveillance, and integrated stewardship strategies to curb the spread of multidrug-resistant Klebsiella.
METHODS: A 12-year retrospective surveillance study (2012-2024) of 9790 non-duplicate Klebsiella isolates from Aseer Central Hospital in southern Saudi Arabia. Species-level identification, antimicrobial susceptibility testing for each isolate was done. Molecular characterization of carbapenemase genes for selected isolates were performed. Temporal resistance trends were assessed using logistic regression.
RESULTS: K. pneumoniae accounted for 93.0% of isolates, with non-pneumoniae species showing distinct resistance profiles. Carbapenem resistance surged from 12.4% in 2012 to 69.3% in 2021, while DTR prevalence rose to 50.7%. ICU and inpatient settings exhibited the highest resistance rates. Molecular testing revealed widespread bla_OXA-48-like (35.7%), bla_NDM (17.9%), and emerging bla_KPC (14.3%) genes, with 25% of isolates co-harboring multiple carbapenemases. Progression from colonization to bloodstream infection occurred in 1.7% of K. pneumoniae cases, primarily from respiratory and urinary sources.
CONCLUSION: This study highlights escalating carbapenem and DTR resistance among Klebsiella species in southern Saudi Arabia, driven by species-specific mechanisms and widespread carbapenemase gene dissemination. Findings underscore the need for species-level diagnostics, expanded molecular surveillance, and integrated stewardship strategies to curb the spread of multidrug-resistant Klebsiella.